Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
2010
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Clinical implications of epithelial cell plasticity in cancer progression
2015
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
2015
Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules
2004 StandoutNobel
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future
2004
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
TRIM proteins and cancer
2011
Roles of the immune system in cancer: from tumor initiation to metastatic progression
2018
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
2009
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
The Role of Plasminogen-Plasmin System in Cancer
2009
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
2016
TGFβ signalling in context
2012 Standout
The extracellular matrix protein fibronectin is a substrate for kallikrein 7
2008
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Challenges in circulating tumour cell research
2014
Macrophages in immunoregulation and therapeutics
2023 Standout
Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains
2011
The biology and function of fibroblasts in cancer
2016 Standout
Human natural killer cells: their origin, receptors and function
2002
A Collective Route to Head and Neck Cancer Metastasis
2018
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors
2005
Symmetry Recognizing Asymmetry
2003 StandoutNobel
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
2016
Crucial Roles of Sp1 and Epigenetic Modifications in the Regulation of the CLDN4 Promoter in Ovarian Cancer Cells
2006
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Antitumour actions of interferons: implications for cancer therapy
2016
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer
2017
Recurrent implantation failure: definition and management
2013 Standout
Genetic upregulation of matriptase‐2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation
2008
Differences in expression patterns of the tight junction proteins,claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours
2005
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Extracellular matrix structure
2015 Standout
Recent advances in understanding immunology of reproductive failure
2011
TCR Specificity Dictates CD94/NKG2A Expression by Human CTL
2002
Clinical Significance of Human Kallikrein7 Gene Expression in Colorectal Cancer
2010
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer
2012
Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes
2010
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
2015
Type II transmembrane serine proteases in development and disease
2007
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Oxidative Stress in Cancer
2020 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Progress in Exosome Isolation Techniques
2017 Standout
Hidradenitis suppurativa
2020 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Phosphorylation of Claudin-3 at Threonine 192 by cAMP-dependent Protein Kinase Regulates Tight Junction Barrier Function in Ovarian Cancer Cells
2005
Human NK cells and their receptors
2002
Clinical applications of the CellSearch platform in cancer patients
2018
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
2017
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
2019
Tumor Immunology and Tumor Evolution: Intertwined Histories
2020
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
2014
Biology, vulnerabilities and clinical applications of circulating tumour cells
2022
Regulation of self-tolerance by Qa-1-restricted CD8+ regulatory T cells
2011
The evolving translational potential of small extracellular vesicles in cancer
2020
NK CELL RECOGNITION
2004 Standout
Tumor Exosomes: Cellular Postmen of Cancer Diagnosis and Personalized Therapy
2016
Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases
2017
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro
2013 StandoutNobel
EMT and inflammation: inseparable actors of cancer progression
2017
Analysis of HLA-E Peptide-Binding Specificity and Contact Residues in Bound Peptide Required for Recognition by CD94/NKG2
2003
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
2003
Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients
2007
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Epithelial–mesenchymal transition in tumor metastasis
2016
EMT, CTCs and CSCs in tumor relapse and drug-resistance
2015
Cell-free DNA level as a prognostic biomarker for epithelial ovarian cancer.
2012
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of Simone Anfossi being referenced
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
2014
High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer
2014
Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
2012
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer
2008
The novel serine protease tumor‐associated differentially expressed gene–15 (matriptase/MT‐SP1) is highly overexpressed in cervical carcinoma
2003
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer
2016
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
2004
Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer
2014
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells
2015
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR α/β-mediated recognition
2001
Breast cancer circulating biomarkers: advantages, drawbacks, and new insights
2015
Clinical utility of circulating non-coding RNAs — an update
2018
The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells
2004
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
2016